Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix

Biomaterials

Volumn 24, Issue 27, 2003, Pages 5009-5014

  Kofidis, T ^a,b,c,d   Lenz, A ^a,c   Boublik, J ^a,c   Akhyari, P ^a,c   Wachsmann, B ^a,c   Mueller Stahl, K ^a,c   Hofmann, M ^a   Haverich, A ^a,b,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b ARTISS GmbH   (Germany)

^c Leibniz Res Labs Artif Organs B   (Germany)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Cardiac tissue engineering; Collagen structure; Organ culture; Viability

Indexed keywords

BIOREACTORS; GLUCOSE; METABOLISM; POSITRON EMISSION TOMOGRAPHY; TISSUE;

CELLULAR VIABILITY;

IMPLANTS (SURGICAL);

FIBRIN GLUE; FLUORODEOXYGLUCOSE F 18;

ANIMAL TISSUE; ARTICLE; BIOREACTOR; CELL MIGRATION; CELL VIABILITY; CONTROLLED STUDY; GLUCOSE TRANSPORT; HEART MUSCLE CELL; NEWBORN; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PULSATILE FLOW; RAT; SOLID; TISSUE CULTURE;

EID: 0141920761     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(03)00429-0     Document Type: Article

References (22)

1. Naughton G.K. From lab bench to market. critical issues in tissue engineering Ann N Y Acad Sci. 96:2002;372-385.
2. Hutmacher D.W., Goh J.C., Teoh S.H. An introduction to biodegradable materials for tissue engineering applications. Ann Acad Med Singapore. 30(2):2001;183-191.
3. Hutmacher D.W. Scaffold design and fabrication technologies for engineering tissues - state of the art and future perspectives. J Biomater Sci Polym Ed. 12(1):2001;107-124.
4. Korossis S.A., Booth C., Wilcox H.E., Watterson K.G., Kearney J.N., Fisher J., Ingham E. Tissue engineering of cardiac valve prostheses II. biomechanical characterization of decellularized porcine aortic heart valves J Heart Valve Dis. 11(4):2002;463-471.
5. Ozawa T., Mickle D.A., Weisel R.D., Koyama N., Ozawa S., Li R.K. Optimal biomaterial for creation of autologous cardiac grafts. Circulation. 106(12 Suppl. 1):2002;I176-I182.
6. Akhyari P., Fedak P.W., Weisel R.D., Lee T.Y., Verma S., Mickle D.A., Li R.K. Mechanical stretch regimen enhances the formation of bioengineered autologous cardiac muscle grafts. Circulation. 106(12 Suppl 1):2002;I137-I142.
7. Davisson T., Kunig S., Chen A., Sah R., Ratcliffe A. Static and dynamic compression modulate matrix metabolism in tissue engineered cartilage. J Orthop Res. 20(4):2002;842-848.
8. Baek C.H., Lee J.C., Jung Y.G., Ko Y.J., Yoon J.J., Park T.G. Tissue-engineered cartilage on biodegradable macroporous scaffolds. cell shape and phenotypic expression Laryngoscope. 112(6):2002;1050-1055.
9. Kofidis T., Akhyari P., Boublik J., Theodorou P., Martin U., Ruhparwar A., Fischer S., Eschenhagen T., Kubis H.P., Kraft T., Leyh R., Haverich A. In vitro engineering of heart muscle. artificial myocardial tissue J Thorac Cardiovasc Surg. 124(1):2002;63-69.
10. Vailhe B., Ronot X., Tracqui P., Usson Y., Tranqui L. In vitro angiogenesis is modulated by the mechanical properties of fibrin gels and is related to alpha(v)beta3 integrin localization. In Vitro Cell Dev Biol Anim. 33(10):1997;763-773.
11. Wilting J., Christ B., Bokeloh M., Weich H.A. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane. Cell Tissue Res. 274(1):1993;163-172.
12. Kim J.A., Shu S. Adoptive immunotherapy. Methods Mol Med. 75:2000;697-710.
13. Van Luyn M., Tio R., Gallego y van Seijen X., Plantinga J., de Leij L., DeJongste M., van Wachem P. Cardiac tissue engineering. characteristics of in unison contracting two- and three-dimensional neonatal rat ventricle cell (co)-cultures Biomaterials. 23(24):2002;4793.
14. Papadaki M., Bursac N., Langer R., Merok J., Vunjak-Novakovic G., Freed L.E. Tissue engineering of functional cardiac muscle. molecular, structural, and electrophysiological studies Am J Physiol Heart Circ Physiol. 280(1):2001;H168-H178.
15. Carrier R.L., Papadaki M., Rupnick M., Schoen F.J., Bursac N., Langer R., Freed L.E., Vunjak-Novakovic G. Cardiac tissue engineering. cell seeding, cultivation parameters, and tissue construct characterization Biotechnol Bioeng. 64(5):1999;580-589.
16. Dumont K., Yperman J., Verbeken E., Segers P., Meuris B., Vandenberghe S., Flameng W., Verdonck P.R. Design of a new pulsatile bioreactor for tissue engineered aortic heart valve formation. Artif Organs. 26(8):2002;710-714.
17. Lwigale P.Y., Thurmond J.E., Norton W.N., Spooner B.S., Wiens D.J. Simulated microgravity and hypergravity attenuate heart tissue development in explant culture. Cells Tissues Organs. 167(2-3):2000;171-183.
18. Hoerstrup S.P., Sodian R., Sperling J.S., Vacanti J.P., Mayer J.E. Jr. New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng. 6(1):2000;75-79.
19. Akins R.E., Boyce R.A., Madonna M.L., Schroedl N.A., Gonda S.R., McLaughlin T.A., Hartzell C.R. Cardiac organogenesis in vitro. reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells Tissue Eng. 5(2):1999;103-118.
20. Assouline M., Chew S.J., Thompson H.W., Beuerman R. Effect of growth factors on collagen lattice contraction by human keratocytes. Invest Ophthalmol Vis Sci. 33:1992;1742-1755.
21. Bell R.S., Bouret L.A., Bell D.F., Gebhardt M.C., Rosenberg A., Treadwell B.V., Tomford W.W., Mankin H.J. Evaluation of fluorescein diacetate for flow cytometric determination of cell viability in orthopedic research. J Orthop Res. 6:1988;467-474.
22. Ratcliffe A., Niklason L.E. Bioreactors and bioprocessing for tissue engineering. Ann N Y Acad Sci. 961:2002;210-215.